Beskrivelse
This presentation will discuss the most recent developments relating to the “industrial application” requirement with a special emphasis on gene and protein-related inventions in Europe. In addition to providing a brief overview of the applicable legislative framework, this presentation will address relevant EPO practice and the UK Supreme Court’s seminal decision in HGS v Eli Lilly.| Periode | 12 aug. 2013 |
|---|---|
| Begivenhedstitel | Pharmaceutical Law & Policy- Hot topics shaping the future of the pharma industry: Copenhagen Summer University 2013 |
| Begivenhedstype | Kursus |
| Placering | Copenhagen, DanmarkVis på kort |
Dokumenter og Links
Relateret indhold
-
Publikation
-
The industrial application requirement for biotech inventions in light of recent EPO & UK case law: A plausible "hunting license"?"
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review